DK0804246T3 - Mitomycinholdige lægemiddelleveringssystemer - Google Patents
Mitomycinholdige lægemiddelleveringssystemerInfo
- Publication number
- DK0804246T3 DK0804246T3 DK94923825T DK94923825T DK0804246T3 DK 0804246 T3 DK0804246 T3 DK 0804246T3 DK 94923825 T DK94923825 T DK 94923825T DK 94923825 T DK94923825 T DK 94923825T DK 0804246 T3 DK0804246 T3 DK 0804246T3
- Authority
- DK
- Denmark
- Prior art keywords
- mmc
- pct
- groups
- carrier polymer
- spacer
- Prior art date
Links
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 title abstract 6
- 229930192392 Mitomycin Natural products 0.000 title abstract 5
- 229960004857 mitomycin Drugs 0.000 title abstract 5
- 238000012377 drug delivery Methods 0.000 title 1
- 125000003277 amino group Chemical group 0.000 abstract 3
- 229920000642 polymer Polymers 0.000 abstract 3
- 230000008878 coupling Effects 0.000 abstract 2
- 238000010168 coupling process Methods 0.000 abstract 2
- 238000005859 coupling reaction Methods 0.000 abstract 2
- 125000006850 spacer group Chemical group 0.000 abstract 2
- 230000003213 activating effect Effects 0.000 abstract 1
- 125000004069 aziridinyl group Chemical group 0.000 abstract 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9317213A GB2282384B8 (en) | 1993-08-18 | 1993-08-18 | Drug delivery agents incorporating mitomycin |
| PCT/IB1994/000259 WO1995005200A1 (en) | 1993-08-18 | 1994-08-17 | Drug delivery agents incorporating mitomycin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0804246T3 true DK0804246T3 (da) | 2000-11-13 |
Family
ID=10740702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94923825T DK0804246T3 (da) | 1993-08-18 | 1994-08-17 | Mitomycinholdige lægemiddelleveringssystemer |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5738864A (da) |
| EP (1) | EP0804246B1 (da) |
| JP (1) | JPH09501674A (da) |
| AT (1) | ATE192933T1 (da) |
| CA (1) | CA2168007C (da) |
| DE (1) | DE69424577T2 (da) |
| DK (1) | DK0804246T3 (da) |
| ES (1) | ES2145832T3 (da) |
| GB (1) | GB2282384B8 (da) |
| GR (1) | GR3034174T3 (da) |
| PT (1) | PT804246E (da) |
| WO (1) | WO1995005200A1 (da) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5850855A (en) * | 1990-01-09 | 1998-12-22 | Ems-Inventa Ag | Flexible coolant conduit and method of making same |
| EA002547B1 (ru) * | 1997-02-26 | 2002-06-27 | Эли Лилли Энд Компани | Способ селективного эпоксидирования для получения лекарственных соединений |
| US6251866B1 (en) | 1997-08-05 | 2001-06-26 | Watson Laboratories, Inc. | Conjugates targeted to the interleukin-2 receptor |
| US6919076B1 (en) | 1998-01-20 | 2005-07-19 | Pericor Science, Inc. | Conjugates of agents and transglutaminase substrate linking molecules |
| US6958148B1 (en) | 1998-01-20 | 2005-10-25 | Pericor Science, Inc. | Linkage of agents to body tissue using microparticles and transglutaminase |
| MXPA01004239A (es) * | 1998-10-30 | 2002-06-04 | Daiichi Seiyaku Co | Compuesto dds y metodo para la medicion del mismo. |
| WO2002020663A2 (en) * | 2000-09-06 | 2002-03-14 | Ap Pharma, Inc. | Degradable polyacetal polymers |
| US20030124742A1 (en) * | 2001-08-22 | 2003-07-03 | Prakash Ramesh K. | Conjugates targeted to target receptors |
| AU2004233997C1 (en) * | 2003-04-29 | 2014-01-30 | Massachusetts Institiute Of Technology | Methods and devices for the sustained release of multiple drugs |
| WO2006020722A2 (en) * | 2004-08-11 | 2006-02-23 | Arqule, Inc. | Polymer conjugates of beta-lapachone and beta-lapachone analogs for tumor targeting |
| US8614228B2 (en) | 2004-08-11 | 2013-12-24 | Arqule, Inc. | Quinone prodrug compositions and methods of use |
| CA2631704A1 (en) | 2005-12-05 | 2007-06-14 | Nitto Denko Corporation | Polyglutamate-amino acid conjugates and methods |
| US20080181852A1 (en) * | 2007-01-29 | 2008-07-31 | Nitto Denko Corporation | Multi-functional Drug Carriers |
| JP5286822B2 (ja) * | 2007-02-22 | 2013-09-11 | Ｊｓｒ株式会社 | ポリアミノ酸またはポリアミノ酸系共重合体の製造方法 |
| US20080253969A1 (en) * | 2007-04-10 | 2008-10-16 | Nitto Denko Corporation | Multi-functional polyglutamate drug carriers |
| MX2009011822A (es) | 2007-04-30 | 2010-01-14 | Arqule Inc | Hidroxi sulfonatos de compuestos de quinonicos y sus usos. |
| KR20100017540A (ko) | 2007-05-09 | 2010-02-16 | 닛토덴코 가부시키가이샤 | 소수성 화합물 및 폴리아미노산 콘쥬게이트를 포함하는 조성물 |
| JP2010526917A (ja) * | 2007-05-09 | 2010-08-05 | 日東電工株式会社 | 複数種の薬物を有するポリグルタミン酸塩複合体及びポリグルタミン酸塩−アミノ酸複合体 |
| WO2008141111A2 (en) * | 2007-05-09 | 2008-11-20 | Nitto Denko Corporation | Polymers conjugated with platinum drugs |
| RU2010137032A (ru) * | 2008-03-06 | 2012-04-20 | Нитто Денко Корпорейшн (Jp) | Конъюгаты паклитаксела с полимером и способы лечения рака |
| US20200164078A1 (en) * | 2017-07-17 | 2020-05-28 | Technische Universiteit Eindhoven | Applicable chemical composition comprising an agent conjugated to a hydrophobic moiety and a carrier |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1541436A (en) * | 1976-02-02 | 1979-02-28 | Searle & Co | Immunological materials |
| JP2528477B2 (ja) * | 1987-09-07 | 1996-08-28 | 三共株式会社 | 高分子制癌剤の増強剤 |
| AU628846B2 (en) * | 1988-08-23 | 1992-09-24 | Georgetown University | Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof |
| JPH0762049B2 (ja) * | 1991-03-18 | 1995-07-05 | 工業技術院長 | 高分子マイトマイシンｃ誘導体及びその製造方法 |
| JPH05252673A (ja) * | 1992-03-05 | 1993-09-28 | Honda Motor Co Ltd | 電源装置 |
-
1993
- 1993-08-18 GB GB9317213A patent/GB2282384B8/en not_active Expired - Fee Related
-
1994
- 1994-08-17 AT AT94923825T patent/ATE192933T1/de not_active IP Right Cessation
- 1994-08-17 WO PCT/IB1994/000259 patent/WO1995005200A1/en not_active Ceased
- 1994-08-17 EP EP94923825A patent/EP0804246B1/en not_active Expired - Lifetime
- 1994-08-17 DK DK94923825T patent/DK0804246T3/da active
- 1994-08-17 PT PT94923825T patent/PT804246E/pt unknown
- 1994-08-17 ES ES94923825T patent/ES2145832T3/es not_active Expired - Lifetime
- 1994-08-17 US US08/602,733 patent/US5738864A/en not_active Expired - Fee Related
- 1994-08-17 DE DE69424577T patent/DE69424577T2/de not_active Expired - Fee Related
- 1994-08-17 CA CA002168007A patent/CA2168007C/en not_active Expired - Fee Related
- 1994-08-17 JP JP7506852A patent/JPH09501674A/ja active Pending
-
2000
- 2000-08-10 GR GR20000401869T patent/GR3034174T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995005200A1 (en) | 1995-02-23 |
| US5738864A (en) | 1998-04-14 |
| JPH09501674A (ja) | 1997-02-18 |
| GB2282384A (en) | 1995-04-05 |
| DE69424577T2 (de) | 2001-02-22 |
| PT804246E (pt) | 2000-08-31 |
| GR3034174T3 (en) | 2000-11-30 |
| GB9317213D0 (en) | 1993-10-06 |
| ATE192933T1 (de) | 2000-06-15 |
| EP0804246A1 (en) | 1997-11-05 |
| GB2282384B (en) | 1997-09-03 |
| ES2145832T3 (es) | 2000-07-16 |
| CA2168007C (en) | 2001-06-12 |
| EP0804246B1 (en) | 2000-05-17 |
| DE69424577D1 (de) | 2000-06-21 |
| CA2168007A1 (en) | 1995-02-23 |
| GB2282384B8 (en) | 1997-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE192933T1 (de) | Mitomycin enthaltende arzneimittelabgabesysteme | |
| CA2187346C (en) | Receptor modulating agents and methods relating thereto | |
| ATE208645T1 (de) | Gerät zum injizieren eines pharmazeutischen präparats in festem zustand | |
| GEP20012413B (en) | Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents | |
| SE9300140D0 (sv) | Solid substrate | |
| CA2159452A1 (en) | Needleless Syringe Using Supersonic Gas Flow for Particle Delivery | |
| AU3506893A (en) | Use of fullerenes in diagnostic and/or therapeutic agents | |
| BR9406893A (pt) | Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids | |
| EP0668720A4 (en) | M-EDTA PHARMACEUTICAL PREPARATIONS AND THEIR USE. | |
| GEP20022788B (en) | Pharmaceutical Compositions Having Appetite Suppressant Activity | |
| DE59609501D1 (de) | Kristallmodifikation des CDCH, Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
| DK0869808T3 (da) | Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation | |
| ATE177657T1 (de) | Intravaginales wirkstoffabgabesystem | |
| ES2110097T3 (es) | Sistema de liberacion basado en proteinas. | |
| ATE316794T1 (de) | Pharmazeutische zusammensetzungen enthaltend lysostaphin allein oder in kombination mit einem antibiotikum zur behandlung von staphylokokkeninfektionen | |
| GEP20012439B (en) | Aniline Derivatives Having Nitrogen Monoxide Synthase Inhibitory Activity and Pharmaceutical Compositions Containing the Same | |
| GEP20002206B (en) | Cryptophycins, Method for its Production, Pharmaceutical Composition on Their basis and Use | |
| YU36401A (sh) | Farmaceutska kompozicija za stimulator osetljivosti na insulin sa modifikovanim ispuštanjem | |
| ATE272648T1 (de) | Glycokonjugate von 20(s)-camptothecin | |
| RU93016671A (ru) | Иммуномодулятор | |
| AU2796295A (en) | New derivatives of oligosides, their process of preparation and their applications | |
| IL112435A0 (en) | A pharmaceutical composition containing an acid active substance and processes for the preparation thereof | |
| RU94046312A (ru) | Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные | |
| DE69321096D1 (de) | Katecholamine-diphosphate und diese enthaltende arzneimittel | |
| RU95105590A (ru) | Гепатотропные конъюгаты антивирусных лекарственных средств, их носители, содержащие их фармацевтические композиции, способ получения конъюгатов |